本报记者王宁今年以来,创新药板块表现活跃,成为公募基金重要布局主线之一。Wind资讯数据显示,截至10月19日,万得创新药指数年内累计涨幅已超30%,同时,创新药主题基金业绩表现较强,例如多达22只产品年内净值增长率超过50%;此外,其主题基金总规模已增至600亿元,较年初增长330亿元。多位受访的基金经理对《证券日报》记者表示,年内创新药产业持续呈现较好发展态势,如中国药企对外授权交易金额大幅...
Source Link本报记者王宁今年以来,创新药板块表现活跃,成为公募基金重要布局主线之一。Wind资讯数据显示,截至10月19日,万得创新药指数年内累计涨幅已超30%,同时,创新药主题基金业绩表现较强,例如多达22只产品年内净值增长率超过50%;此外,其主题基金总规模已增至600亿元,较年初增长330亿元。多位受访的基金经理对《证券日报》记者表示,年内创新药产业持续呈现较好发展态势,如中国药企对外授权交易金额大幅...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.